Pramipexole dihydrochloride
98%
- Product Code: 52291
CAS:
104632-25-9
| Molecular Weight: | 284.25 g./mol | Molecular Formula: | C₁₀H₁₉Cl₂N₃S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00876894 | |
| Melting Point: | 288-290°C | Boiling Point: | |
| Density: | Storage Condition: | 2-8°C |
Product Description:
Pramipexole dihydrochloride is primarily used in the treatment of Parkinson's disease. It works by stimulating dopamine receptors in the brain, helping to alleviate symptoms such as tremors, stiffness, and slow movement. This medication is often prescribed when other treatments are not effective or to complement existing therapies.
Additionally, it is used to manage restless legs syndrome (RLS), a condition characterized by uncomfortable sensations in the legs and an irresistible urge to move them. By acting on the dopamine system, it helps reduce the symptoms, particularly during periods of rest or sleep.
The drug is typically administered orally in tablet form, with dosage adjusted based on the patient's response and tolerance. Regular monitoring by a healthcare provider is essential to ensure optimal effectiveness and minimize potential side effects.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Very pale yellow Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | Ft7,326.39 |
+
-
|
| 0.250 | 10-20 days | Ft24,564.97 |
+
-
|
| 1.000 | 10-20 days | Ft55,163.43 |
+
-
|
Pramipexole dihydrochloride
Pramipexole dihydrochloride is primarily used in the treatment of Parkinson's disease. It works by stimulating dopamine receptors in the brain, helping to alleviate symptoms such as tremors, stiffness, and slow movement. This medication is often prescribed when other treatments are not effective or to complement existing therapies.
Additionally, it is used to manage restless legs syndrome (RLS), a condition characterized by uncomfortable sensations in the legs and an irresistible urge to move them. By acting on the dopamine system, it helps reduce the symptoms, particularly during periods of rest or sleep.
The drug is typically administered orally in tablet form, with dosage adjusted based on the patient's response and tolerance. Regular monitoring by a healthcare provider is essential to ensure optimal effectiveness and minimize potential side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :